Posted on 12/22/2020
This affordable device enables Enzo to offer a complete solution to academic, CRO, and industrial customers
NEW YORK, NY — November 5, 2020 — Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced today the commercial launch of a small portable microplate reader for use with the company’s immunoassays and, ultimately, molecular diagnostics, providing new opportunities in point-of-care medicine. This affordable device enables Enzo to offer a com...